JAZZ Annual CAPEX
$42.96 M
-$455.23 M-91.38%
31 December 2023
Summary:
As of January 22, 2025, JAZZ annual capital expenditures is $42.96 million, with the most recent change of -$455.23 million (-91.38%) on December 31, 2023. During the last 3 years, it has fallen by -$336.29 million (-88.67%). JAZZ annual CAPEX is now -91.38% below its all-time high of $498.19 million, reached on December 31, 2022.JAZZ CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JAZZ Quarterly CAPEX
$10.79 M
+$3.70 M+52.14%
30 September 2024
Summary:
As of January 22, 2025, JAZZ quarterly capital expenditures is $10.79 million, with the most recent change of +$3.70 million (+52.14%) on September 30, 2024. Over the past year, it has increased by +$6.49 million (+150.94%). JAZZ quarterly CAPEX is now -97.19% below its all-time high of $384.38 million, reached on December 31, 2022.JAZZ Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JAZZ TTM CAPEX
$62.88 M
+$6.49 M+11.51%
30 September 2024
Summary:
As of January 22, 2025, JAZZ TTM capital expenditures is $62.88 million, with the most recent change of +$6.49 million (+11.51%) on September 30, 2024. Over the past year, it has dropped by -$336.35 million (-84.25%). JAZZ TTM CAPEX is now -87.38% below its all-time high of $498.19 million, reached on December 31, 2022.JAZZ TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JAZZ CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -91.4% | +150.9% | -84.3% |
| 3 y3 years | -88.7% | +150.9% | -84.3% |
| 5 y5 years | -67.3% | +150.9% | -84.3% |
JAZZ CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -91.4% | at low | -97.2% | +320.1% | -87.4% | +46.4% |
| 5 y | 5-year | -91.4% | at low | -97.2% | +320.1% | -87.4% | +46.4% |
| alltime | all time | -91.4% | +2940.5% | -97.2% | +320.1% | -87.4% | >+9999.0% |
Jazz Pharmaceuticals CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $10.79 M(+52.1%) | $62.88 M(+11.5%) |
| June 2024 | - | $7.09 M(-58.1%) | $56.40 M(+2.5%) |
| Mar 2024 | - | $16.90 M(-39.8%) | $55.04 M(+28.1%) |
| Dec 2023 | $42.96 M(-91.4%) | $28.10 M(+553.7%) | $42.96 M(-89.2%) |
| Sept 2023 | - | $4.30 M(-25.1%) | $399.24 M(+2.4%) |
| June 2023 | - | $5.74 M(+19.0%) | $390.04 M(-16.3%) |
| Mar 2023 | - | $4.82 M(-98.7%) | $465.72 M(-6.5%) |
| Dec 2022 | $498.19 M(+994.2%) | $384.38 M(-7941.2%) | $498.19 M(+302.5%) |
| Sept 2022 | - | -$4.90 M(-106.0%) | $123.78 M(-20.1%) |
| June 2022 | - | $81.43 M(+118.3%) | $154.90 M(+92.1%) |
| Mar 2022 | - | $37.29 M(+274.2%) | $80.66 M(+77.1%) |
| Dec 2021 | $45.53 M(-88.0%) | $9.97 M(-62.0%) | $45.53 M(-39.8%) |
| Sept 2021 | - | $26.22 M(+265.3%) | $75.68 M(+20.5%) |
| June 2021 | - | $7.18 M(+231.1%) | $62.83 M(-61.1%) |
| Mar 2021 | - | $2.17 M(-94.6%) | $161.34 M(-57.5%) |
| Dec 2020 | $379.25 M(+108.0%) | $40.12 M(+200.1%) | $379.25 M(+9.5%) |
| Sept 2020 | - | $13.37 M(-87.4%) | $346.28 M(-14.0%) |
| June 2020 | - | $105.69 M(-52.0%) | $402.49 M(+18.9%) |
| Mar 2020 | - | $220.08 M(+2983.6%) | $338.47 M(+85.6%) |
| Dec 2019 | $182.34 M(+38.7%) | $7.14 M(-89.7%) | $182.34 M(+1.1%) |
| Sept 2019 | - | $69.59 M(+67.0%) | $180.35 M(+57.2%) |
| June 2019 | - | $41.66 M(-34.8%) | $114.70 M(-39.1%) |
| Mar 2019 | - | $63.95 M(+1141.9%) | $188.27 M(+43.2%) |
| Dec 2018 | $131.47 M(+15.4%) | $5.15 M(+30.8%) | $131.47 M(-8.2%) |
| Sept 2018 | - | $3.94 M(-96.6%) | $143.20 M(-35.7%) |
| June 2018 | - | $115.23 M(+1511.9%) | $222.61 M(+89.4%) |
| Mar 2018 | - | $7.15 M(-57.6%) | $117.53 M(+3.1%) |
| Dec 2017 | $113.95 M(-37.9%) | $16.88 M(-79.7%) | $113.95 M(+15.9%) |
| Sept 2017 | - | $83.35 M(+721.1%) | $98.35 M(+203.7%) |
| June 2017 | - | $10.15 M(+184.0%) | $32.38 M(-81.6%) |
| Mar 2017 | - | $3.57 M(+179.9%) | $175.79 M(-4.2%) |
| Dec 2016 | $183.44 M(+410.1%) | $1.28 M(-92.7%) | $183.44 M(-1.1%) |
| Sept 2016 | - | $17.38 M(-88.7%) | $185.53 M(+7.1%) |
| June 2016 | - | $153.56 M(+1268.3%) | $173.30 M(+428.8%) |
| Mar 2016 | - | $11.22 M(+233.3%) | $32.77 M(-8.9%) |
| Dec 2015 | $35.96 M | $3.37 M(-34.7%) | $35.96 M(-23.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2015 | - | $5.16 M(-60.4%) | $46.77 M(-62.5%) |
| June 2015 | - | $13.02 M(-9.6%) | $124.75 M(-0.1%) |
| Mar 2015 | - | $14.41 M(+1.7%) | $124.86 M(-47.8%) |
| Dec 2014 | $238.97 M(+1369.3%) | $14.17 M(-83.0%) | $238.97 M(+4.9%) |
| Sept 2014 | - | $83.14 M(+533.1%) | $227.90 M(+54.1%) |
| June 2014 | - | $13.13 M(-89.8%) | $147.91 M(+6.9%) |
| Mar 2014 | - | $128.53 M(+4043.4%) | $138.35 M(+750.6%) |
| Dec 2013 | $16.26 M(-27.6%) | $3.10 M(-1.6%) | $16.26 M(-18.3%) |
| Sept 2013 | - | $3.15 M(-11.6%) | $19.89 M(-2.9%) |
| June 2013 | - | $3.57 M(-44.6%) | $20.49 M(-25.2%) |
| Mar 2013 | - | $6.44 M(-4.3%) | $27.38 M(+21.8%) |
| Dec 2012 | $22.48 M(+288.9%) | $6.73 M(+79.6%) | $22.48 M(+27.5%) |
| Sept 2012 | - | $3.75 M(-64.2%) | $17.62 M(+14.7%) |
| June 2012 | - | $10.46 M(+581.4%) | $15.36 M(+150.9%) |
| Mar 2012 | - | $1.53 M(-18.4%) | $6.12 M(+6.0%) |
| Dec 2011 | $5.78 M(+22.2%) | $1.88 M(+26.5%) | $5.78 M(+15.3%) |
| Sept 2011 | - | $1.49 M(+21.9%) | $5.01 M(+3.5%) |
| June 2011 | - | $1.22 M(+2.4%) | $4.84 M(+0.1%) |
| Mar 2011 | - | $1.19 M(+7.0%) | $4.84 M(+2.2%) |
| Dec 2010 | $4.73 M(-21.8%) | $1.11 M(-15.4%) | $4.73 M(-28.6%) |
| Sept 2010 | - | $1.32 M(+8.2%) | $6.62 M(-9.7%) |
| June 2010 | - | $1.22 M(+12.0%) | $7.34 M(+19.6%) |
| Mar 2010 | - | $1.09 M(-63.9%) | $6.13 M(+1.3%) |
| Dec 2009 | $6.05 M(-78.9%) | $3.01 M(+48.1%) | $6.05 M(-40.2%) |
| Sept 2009 | - | $2.03 M(>+9900.0%) | $10.12 M(+24.2%) |
| June 2009 | - | $12.00 K(-98.8%) | $8.15 M(-57.8%) |
| Mar 2009 | - | $1.00 M(-85.8%) | $19.29 M(-32.9%) |
| Dec 2008 | $28.74 M(+812.6%) | $7.07 M(>+9900.0%) | $28.74 M(+26.6%) |
| Sept 2008 | - | $56.00 K(-99.5%) | $22.71 M(-2.3%) |
| June 2008 | - | $11.15 M(+6.6%) | $23.25 M(+74.3%) |
| Mar 2008 | - | $10.46 M(+902.7%) | $13.34 M(+323.5%) |
| Dec 2007 | $3.15 M(+87.2%) | $1.04 M(+75.9%) | $3.15 M(+49.5%) |
| Sept 2007 | - | $593.00 K(-52.3%) | $2.11 M(+39.2%) |
| June 2007 | - | $1.24 M(+358.3%) | $1.51 M(+458.3%) |
| Mar 2007 | - | $271.00 K | $271.00 K |
| Dec 2006 | $1.68 M(+19.0%) | - | - |
| Dec 2005 | $1.41 M | - | - |
FAQ
- What is Jazz Pharmaceuticals annual capital expenditures?
- What is the all time high annual CAPEX for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals annual CAPEX year-on-year change?
- What is Jazz Pharmaceuticals quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly CAPEX year-on-year change?
- What is Jazz Pharmaceuticals TTM capital expenditures?
- What is the all time high TTM CAPEX for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals TTM CAPEX year-on-year change?
What is Jazz Pharmaceuticals annual capital expenditures?
The current annual CAPEX of JAZZ is $42.96 M
What is the all time high annual CAPEX for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high annual capital expenditures is $498.19 M
What is Jazz Pharmaceuticals annual CAPEX year-on-year change?
Over the past year, JAZZ annual capital expenditures has changed by -$455.23 M (-91.38%)
What is Jazz Pharmaceuticals quarterly capital expenditures?
The current quarterly CAPEX of JAZZ is $10.79 M
What is the all time high quarterly CAPEX for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high quarterly capital expenditures is $384.38 M
What is Jazz Pharmaceuticals quarterly CAPEX year-on-year change?
Over the past year, JAZZ quarterly capital expenditures has changed by +$6.49 M (+150.94%)
What is Jazz Pharmaceuticals TTM capital expenditures?
The current TTM CAPEX of JAZZ is $62.88 M
What is the all time high TTM CAPEX for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high TTM capital expenditures is $498.19 M
What is Jazz Pharmaceuticals TTM CAPEX year-on-year change?
Over the past year, JAZZ TTM capital expenditures has changed by -$336.35 M (-84.25%)